Martin Andrews
Director/Board Member at Freeline Therapeutics Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Per Lundin | M | 41 |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | 8 years |
| Emma Walmsley | F | 55 | 14 years | |
| Phil Thomson | M | - | 13 years | |
| Amit Chunilal Nathwani | M | 64 |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | 9 years |
| Jesse Goodman | M | 72 | 8 years | |
| Hal Barron | M | 62 | 6 years | |
| Chris Hollowood | M | 50 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | 9 years |
| Tony Wood | M | - | 7 years | |
| Matthew Wood | M | - |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | 8 years |
| Adam Stoten | M | - |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | 8 years |
| Frannie DeFranco | F | - | 14 years | |
| Shobie Ramakrishnan | F | - | 6 years | |
| Diana Conrad | F | - | 8 years | |
| Amrit Nagpal | M | - |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | - |
| Julia Gregory | F | 71 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| María Cristina de Luna Basagoiti | F | - | 14 years | |
| Colin Love | M | 65 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| Sarah Gordon-Wild | F | - |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | - |
| Luke Miels | M | - | 7 years | |
| Jeffrey Chodakewitz | M | 68 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| Victoria Whyte | F | - | 15 years | |
| John McHutchison | M | 66 |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | 3 years |
| Paul Carter | M | 63 |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | 4 years |
| Anita Kidgell | F | - | 16 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Witty | M | 59 | - | |
| Philip Hampton | M | 70 | 4 years | |
| Moncef Slaoui | M | 64 | 11 years | |
| Thomas Mount | M | - | 7 years | |
| Urs Rohner | M | 65 | 9 years | |
| Saul Charles Klein | M | 53 | 2 years | |
| Lynn Elsenhans | F | 68 | 10 years | |
| Murray Stewart | M | 63 | 17 years | |
| Daniel Podolsky | M | 70 | 10 years | |
| Sarah Elton-Farr | F | - | 4 years | |
| Dame Cox | F | 64 | 6 years | |
| William Louv | M | - | 21 years | |
| Jing Ulrich | F | 56 | - | |
| Antonin Rollet de Fougerolles | M | 59 |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | - |
| Anjali Bansal | F | 53 | 6 years | |
| Stephanie Burns | M | 69 | 9 years | |
| Ravi Rao | M | 55 | 7 years | |
| Roy Anderson | M | 76 | 11 years | |
| Vindi Banga | M | 69 | 7 years | |
| Christopher Viehbacher | M | 64 | 20 years | |
| Christopher Gent | M | 75 | 11 years | |
| Robert Carr | M | - | 26 years | |
| Deryck Charles Maughan | M | 76 | 12 years | |
| Ian Maurice Gray Prosser | M | 81 | 9 years | |
| Robert Wilson | M | 81 | 11 years | |
| Judy Lewent | F | 75 | 10 years | |
| Julian Heslop | M | 70 | 13 years | |
| James Murdoch | M | 51 | 3 years | |
| Laurie Glimcher | M | 72 | 5 years | |
| Crispin Davis | M | 75 | 10 years | |
| Stacey Cartwright | F | 60 | 5 years | |
| Tom de Swaan | M | 78 | 9 years | |
| Gerardus Johannes Wijers | M | 74 | 3 years | |
| Simon Dingemans | M | 61 | 8 years | |
| Balbir Kelly Bisla | F | - | 4 years | |
| H. Culp | M | 60 | 9 years | |
| Christopher D. Roberts | M | 54 | - | |
| David Gordon | M | 55 | 11 years | |
| David Chang | M | 61 | 8 years | |
| Wladimir Hogenhuis | M | 59 | 6 years | |
| Lisa Johnson-Pratt | M | 60 | 6 years | |
| Robert Sarrazin | M | - | 5 years | |
| Filippo Lanzi | M | - | 9 years | |
| Cedrik M. Britten | M | 49 | 5 years | |
| Lini Pandite | M | 65 | 14 years | |
| Joe McCann | M | 47 | 4 years | |
| Min Li | M | 62 | 6 years | |
| Hu Li | M | 59 | 19 years | |
| Jing Ji | M | 54 | 4 years | |
| Jay Green | M | 52 | 6 years | |
| Amin Khan | M | 61 | 6 years | |
| Ben Woolven | M | - | 11 years | |
| Raman Singh | M | 53 | 3 years | |
| David M. Pernock | M | 69 | 16 years | |
| Andrew Milne | M | 50 | 1 years | |
| Lawson Macartney | M | 66 | 12 years | |
| Ronaldo Hermann Schmitz | M | 85 | 9 years | |
| Adrian Rawcliffe | M | 52 | 17 years | |
| Atul Pande | M | 69 | 7 years | |
| Ellen Strahlman | M | 66 | 4 years | |
| Eddie J. Gray | M | 64 | 12 years | |
| Yvonne Greenstreet | M | 61 | 2 years | |
| Dan Troy | M | 64 | 10 years | |
| Stephen F. Stefano | M | 68 | 29 years | |
| Bing Li | M | 55 | 4 years | |
| Neil Brewis | M | 57 | 8 years | |
| Michael Owen | M | 73 | 9 years | |
| Catherine Sohn | M | 71 | 28 years | |
| Jay C. Strum | M | - | 14 years | |
| Gregg Brandyberry | M | - | 16 years | |
| Vincent O'Neill | M | 55 | 3 years | |
| Manuel Alves Aivado | M | 53 | 6 years | |
| Johan Heylen | M | 56 | 4 years | |
| Simon Steel | M | - | 8 years | |
| Lon Cardon | M | 58 | 9 years | |
| John Meakin | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin Andrews
- Personal Network
